Expert Speaker Faculty Meet the visionaries shaping the future of pain therapeutics at the 2nd Non-Opioid Pain Therapeutics Summit. Pharma Leaders Driving the Future of Non-Opioid Pain Therapeutics Biotech Innovators Advancing the Next Generation of Pain Medicines Investors & Strategic Leaders Shaping the Future of Pain Innovation Academic & Patient Advocacy Leaders Advancing Pain Biology and Clinical Translation Pharma Leaders Driving the Future of Non-Opioid Pain Therapeutics William Housley Head of Rheumatology Early Discovery (Immunology R&D)AbbVie Peter Borden Director, Search & EvaluationAbbVie John Markman Vice President, Global PainEli Lilly Stephen Zicha Senior Director, NeuroscienceEli Lilly Florian Jakob Head of Drug Discovery EngineGrünenthal Darrell Henze Executive DirectorMerck Erica Bial Medical Director, Clinical Development PainVertex Pharmaceuticals Kavya Gopal Senior Vice President & Disease Area Executive for PainVertex Pharmaceuticals Paul Negulescu Senior Vice President & Disease Area ExecutiveVertex Pharmaceuticals Biotech Innovators Advancing the Next Generation of Pain Medicines Ted Price Co-Founder4E Therapeutics James Campbell President & Chief Scientific OfficerCentrexion Jim Gilligan President & Chief Scientific OfficerEntropy Neurodynamics (formerly Tryp Therapeutics) Bryan Moyer Senior Vice President, DiscoveryLatigo Biotherapeutics Simon Westbrook Founder & Chief Scientific OfficerLevicept Shawn Fatholahi President & Chief Executive OfficerMAXONA Pharmaceuticals Sigal Meilin Chief Scientific OfficerMD Biosciences Ana Moreno Founder & Chief Executive OfficerNavega Therapeutics Shuai Li Founder & Chief Executive OfficerShanghai SimR Biotechnology Errol Gould Vice President, Medical AffairsTONIX Pharmaceuticals Emilio Quetglas Senior Director, Medical & Clinical DevelopmentTris Pharma Christopher Kenney Chief Medical OfficerXenon Pharmaceuticals Investors & Strategic Leaders Shaping the Future of Pain Innovation John Dyer Managing DirectorAquilo Jana Obajdin AnalystBiogeneration Ventures Vincent Nadeau PrincipalBSquared Capital Roman Camarda PrincipalNovo Holdings Academic & Patient Advocacy Leaders Advancing Pain Biology and Clinical Translation Clifford Woolf Director, FM Kirby Neurobiology CentreBoston Children’s Hospital Bruce Bean Professor Harvard Michael Oshinsky Director, Preclinical Pain ResearchNIH Luana Colloca Interim Chair, Pain & Translational Symptom ScienceUniversity of Maryland Cindy Steinberg Director, Policy & AdvocacyUS Pain Foundation Explore the Agenda Dive into 2 tracks, spanning discovery – clinical development and access, 3 preconference day workshops and 30+ expert speakers shaping the future of pain therapeutics Explore the 2027 Agenda Partner With Us Showcase your solutions, connect with decision makers, and position your company as the go-to provider to pain drug developers Explore Sponsorship Options Join Biopharma Experts Network with pharma, biotech, VC, academia, advocacy and regulatory voices driving real-world adoption Register Here